题名 | Embryonic stem cell factors and pancreatic cancer |
作者 | |
发表日期 | 2014-03-07 |
发表期刊 | WORLD JOURNAL OF GASTROENTEROLOGY 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Embryonic stem cells NANOG SOX2 OCT4 Pluripotency Pancreatic cancer Cancer stem cells |
其他关键词 | SELF-RENEWAL ; GEMCITABINE RESISTANCE ; MYELOID-LEUKEMIA ; NANOG EXPRESSION ; C-MET ; IDENTIFICATION ; PLURIPOTENCY ; MOUSE ; OCT4 ; DIFFERENTIATION |
摘要 | Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic tumor, is a highly aggressive human cancer with the lowest five-year survival rate of any human maligancy primarily due to its early-metastasis and lack of response to chemotherapy and radiation. Recent research suggests that PDAC cells comprise a hierarchy of tumor cells that develop around a population of cancer stem cells (CSCs), a small and distinct population of cancer cells that mediates tumoregenesis, metastasis and resistance to standard treatments. Thus, CSCs could be a target for more effective treatment options. Interestingly, pancreatic CSCs are subject to regulation by some of key embryonic stem cell (ESC) transctiption factors abberently expressed in PDAC, such as SOX2, OCT4 and NANOG. ESC transcription factors are important DNA-binding proteins present in both embryonic and adult somatic cells. The critical role of these factors in reprogramming processes makes them essential not only for embryonic development but also tumorigenesis. Here we provide an overview of stem cell transcription factors, particularly SOX2, OCT4, and NANOG, on their expression and function in pancreatic cancer. In contrast to embryonic stem cells, in which OCT4 and SOX2 are tightly regulated and physically interact to regulate a wide spectrum of target genes, de novo SOX2 expression alone in pancreatic cancer cells is sufficient to promote self-renewal, de-differentiation and imparting stemness characteristics via impacting specific cell cycle regulatory genes and epithelial-mesnechymal transtion driver genes. Thus, targeting ESC factors, particularly SOX2, could be a worthy strategy for pancreatic cancer therapy. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved. |
资助项目 | Universidad del Pais Vasco, Instituto Biodonostia, San Sebastian; CIBERehd (red de enfermedades hepaticas y digestivas); American Cancer Society institutional awardAmerican Cancer Society; Mayo Clinic Pancreatic Cancer SPORE [CA102701]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P20CA102701, P50CA102701] Funding Source: NIH RePORTER |
出版者 | BAISHIDENG PUBLISHING GROUP INC |
出版地 | PLEASANTON |
ISSN | 1007-9327 |
EISSN | 2219-2840 |
卷号 | 20期号:9页码:2247-2254 |
DOI | 10.3748/wjg.v20.i9.2247 |
页数 | 8 |
WOS类目 | Gastroenterology & Hepatology |
WOS研究方向 | Gastroenterology & Hepatology |
WOS记录号 | WOS:000332692300014 |
收录类别 | SCIE ; SCOPUS |
URL | 查看原文 |
Pubmed记录号 | 24605024 |
Scopus记录号 | 2-s2.0-84895858886 |
通讯作者地址 | [Zhang, Jin-San]Division of Oncology Research,Schulze Center for Novel Therapeutics,Mayo Clinic College of Medicine,United States |
scopus学科分类 | Gastroenterology |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/11389 |
专题 | 药学院(分析测试中心)_生物制药系_生物制药工程 |
通讯作者 | Zhang, Jin-San |
作者单位 | 1.Division of Oncology Research,Schulze Center for Novel Therapeutics,Mayo Clinic College of Medicine,United States; 2.Department of Gastroenterology,Hospital Donostia/Instituto Biodonostia,Centro de Investigacion Biomedica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd),Universidad del País Vasco UPV/EHU,Spain; 3.School of Pharmaceutical Sciences,Key Laboratory of Biotechnology and Pharmaceutical Engineering,Wenzhou Medical University,China |
推荐引用方式 GB/T 7714 | Herreros-Villanueva, Marta,Bujanda, Luis,Billadeau, Daniel D.,et al. Embryonic stem cell factors and pancreatic cancer[J]. WORLD JOURNAL OF GASTROENTEROLOGY,2014,20(9):2247-2254. |
APA | Herreros-Villanueva, Marta, Bujanda, Luis, Billadeau, Daniel D., & Zhang, Jin-San. (2014). Embryonic stem cell factors and pancreatic cancer. WORLD JOURNAL OF GASTROENTEROLOGY, 20(9), 2247-2254. |
MLA | Herreros-Villanueva, Marta,et al."Embryonic stem cell factors and pancreatic cancer".WORLD JOURNAL OF GASTROENTEROLOGY 20.9(2014):2247-2254. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
ZXXY201409015.CAJ(859KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论